✦ LIBER ✦

PERCUTANEOUS CORONARY INTERVENTIONS WITH ORAL SIROLIMUS AND BARE METAL STENTS ARE COMPARABLE IN SAFETY AND EFFICACY RESULTS TO DRUG ELUTING STENTS: THREE YEARS OUTCOME FROM THE RANDOMIZED ORAR III TRIAL

Book ID: 123531196
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 117 KB
Volume: 57
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(11)61637-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized comparison of cost-saving and

Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: Three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trial

✍ Alfredo E. Rodriguez; Alfredo M. Rodriguez-Granillo; David Antoniucci; Juan Mier 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

First results of the DEB-AMI (drug eluti

First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicentre randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes

✍ Suraj Khànal; Ajay Bahl 📂 Article 📅 2012 🏛 Cardiological Society of India 🌐 English ⚖ 38 KB

First Results of the DEB-AMI (Drug Eluti

First Results of the DEB-AMI (Drug Eluting Balloon in Acute ST-Segment Elevation Myocardial Infarction) Trial: A Multicenter Randomized Comparison of Drug-Eluting Balloon Plus Bare-Metal Stent Versus Bare-Metal Stent Versus Drug-Eluting Stent in Primary Percutaneous Coronary Intervention With 6-Month Angiographic, Intravascular, Functional, and Clinical Outcomes

✍ Anouar Belkacemi; Pierfrancesco Agostoni; Hendrik M. Nathoe; Michiel Voskuil; Ch 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 657 KB

Long-Term Clinical and Economic Analysis

Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent: 4-Year Results From the ENDEAVOR II Trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)

✍ Eric L. Eisenstein; William Wijns; Jean Fajadet; Laura Mauri; Rex Edwards; Patri 📂 Article 📅 2009 🏛 American College of Cardiology 🌐 English ⚖ 364 KB

Rationale and design of the dual antipla

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

✍ Laura Mauri; Dean J. Kereiakes; Sharon-Lise T. Normand; Stephen D. Wiviott; Davi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB